These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6782641)

  • 21. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana.
    Dissanayake S; Shahin A; Ameen AM
    Mol Immunol; 2005 Aug; 42(12):1495-502. PubMed ID: 15950742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections.
    Zimmermann S; Dalpke A; Heeg K
    Int J Med Microbiol; 2008 Jan; 298(1-2):39-44. PubMed ID: 17716944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new method for the partial purification of leishmania amastigotes from cutaneous lesionS.
    Infante RB; Hernandez AG; Riggione F; Dawidowicz K
    Parasitology; 1980 Feb; 80(1):105-12. PubMed ID: 6992056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of immunosuppression in Leishmania mexicana induced lesions in hamsters.
    Sehgal S; Arora SK
    Indian J Med Res; 1985 Sep; 82():202-6. PubMed ID: 4077160
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models.
    Saravia NG; Escorcia B; Osorio Y; Valderrama L; Brooks D; Arteaga L; Coombs G; Mottram J; Travi BL
    Vaccine; 2006 May; 24(19):4247-59. PubMed ID: 16216395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):299-319. PubMed ID: 7396564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Protection against Leishmania donovani induced in hamsters with an irradiated homologous strain].
    Ilardi A; Proietti AM
    Parassitologia; 1974; 16(2-3):143-9. PubMed ID: 4470177
    [No Abstract]   [Full Text] [Related]  

  • 29. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O
    Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm.
    Alexander J; Bryson K
    Immunol Lett; 2005 Jun; 99(1):17-23. PubMed ID: 15894106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania hertigi sp. n., from the tropical porcupine, Coendou rothschildi Thomas.
    Herrer A
    J Parasitol; 1971 Jun; 57(3):626-9. PubMed ID: 5090970
    [No Abstract]   [Full Text] [Related]  

  • 32. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK; Titus RG
    Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of Tridax procumbens against promastigotes of Leishmania mexicana.
    Martín-Quintal Z; Moo-Puc R; González-Salazar F; Chan-Bacab MJ; Torres-Tapia LW; Peraza-Sánchez SR
    J Ethnopharmacol; 2009 Apr; 122(3):463-7. PubMed ID: 19429313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania transmission-blocking vaccines: a review.
    Tonui WK
    East Afr Med J; 1999 Feb; 76(2):93-6. PubMed ID: 10442130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.
    Saravia NG; Hazbón MH; Osorio Y; Valderrama L; Walker J; Santrich C; Cortázar T; Lebowitz JH; Travi BL
    Vaccine; 2005 Jan; 23(8):984-95. PubMed ID: 15620471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH; Gentil LG; Dias SS; Fedeli CE; Katz S; Barbiéri CL
    Vaccine; 2008 Jan; 26(5):677-85. PubMed ID: 18160187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of Langerhans cells in the immunity of leishmaniasis].
    Zuluaga M; Robledo SM
    Biomedica; 2004 Sep; 24(3):302-17. PubMed ID: 15551883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous leishmaniasis: progress towards a vaccine.
    Launois P; Tacchini-Cottier F; Kieny MP
    Expert Rev Vaccines; 2008 Oct; 7(8):1277-87. PubMed ID: 18844599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montenegro's skin reactions and antibodies against different Leishmania species in dogs from a visceral leishmaniosis endemic area.
    Baleeiro CO; Paranhos-Silva M; dos Santos JC; Oliveira GG; Nascimento EG; de Carvalho LP; dos-Santos WL
    Vet Parasitol; 2006 Jun; 139(1-3):21-8. PubMed ID: 16567046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential of KM+ lectin in immunization against Leishmania amazonensis infection.
    Teixeira CR; Cavassani KA; Gomes RB; Teixeira MJ; Roque-Barreira MC; Cavada BS; da Silva JS; Barral A; Barral-Netto M
    Vaccine; 2006 Apr; 24(15):3001-8. PubMed ID: 16455170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.